Press releases
- Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
- Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
- Bruker to Acquire the NanoString Business in an Asset Deal
- Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
- Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
- Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition
- Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
- Bruker Corporation to Present at Upcoming Investor Conferences
More ▼
Key statistics
As of last trade Bruker Corp (BKD:BER) traded at 74.74, -13.60% below its 52-week high of 86.50, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 74.74 |
---|---|
High | 74.74 |
Low | 74.74 |
Bid | 74.00 |
Offer | 75.50 |
Previous close | 76.04 |
Average volume | 63.78 |
---|---|
Shares outstanding | 145.33m |
Free float | 97.12m |
P/E (TTM) | 27.72 |
Market cap | 11.71bn USD |
EPS (TTM) | 2.91 USD |
Annual div (ADY) | 0.1851 EUR |
---|---|
Annual div yield (ADY) | 0.24% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of Apr 26 2024 07:08 BST.
More ▼